Diagnosis and management of von Willebrand Disease: A developing country perspective

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 5, 2011, Pages 587-594

  Chandran Nair, Sukesh ^a   Viswabandya, Auro ^a   Srivastava, Alok ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

developing countries; diagnosis; therapy; von Willebrand disease

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; COLLAGEN BINDING PROTEIN; CONTRACEPTIVE AGENT; DANAZOL; DESMOPRESSIN; RISTOCETIN; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADULT; BLEEDING TIME; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATE; DEVELOPING COUNTRY; ENDOMETRIUM ABLATION; HEMOSTASIS; HUMAN; HYSTERECTOMY; INDIA; MAJOR CLINICAL STUDY; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOCYTE AGGLUTINATION; VON WILLEBRAND DISEASE;

CLINICAL LABORATORY TECHNIQUES; COAGULANTS; DEAMINO ARGININE VASOPRESSIN; DEVELOPING COUNTRIES; FACTOR VIII; HUMANS; TRANEXAMIC ACID; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 81755176080     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1281047     Document Type: Review

References (34)

1. Nichols WL, Hultin MB, James AH et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008 14 2 171-232 (Pubitemid 351343618)
2. Srivastava A. von Willebrand disease in the developing world. Semin Hematol 2005 42 1 36-41 (Pubitemid 40127268)
3. Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost 2005 31 5 569-576 (Pubitemid 41642571)
4. Stonebraker JS, Bolton-Maggs PH, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010 16 1 20-32
5. Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous venostasis bleeding time technique. J Lab Clin Med 1941 26 1812-1822
6. Koster T, Caekebeke-Peerlinck KM, Briet E. A randomized and blinded comparison of the sensitivity and the reproducibility of the Ivy and Simplate II bleeding time techniques. Am J Clin Pathol 1989 92 3 315-320 (Pubitemid 19228930)
7. Favaloro EJ. Toward a new paradigm for the identification and functional characterization of von Willebrand disease. Semin Thromb Hemost 2009 35 1 60-75
8. Lattuada A, Preda L, Sacchi E, Gallo L, Federici AB, Rossi E. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000). Blood Coagul Fibrinolysis 2004 15 6 505-511 (Pubitemid 39180237)
9. Sakthivel MSM, Nair SC, Srivastava A et al. Ristocetin cofactor (VWF:RCo) assaya comparison of a rapid automated method on ACL 10000 coagulometer and conventional aggregometry. J Thromb Haemost 2005 3 Suppl 1 P0868
10. Lawrie AS, Mackie IJ, Machin SJ, Peyvandi F. Evaluation of an automated platelet-based assay of ristocetin cofactor activity. Haemophilia 2011 17 2 252-256
11. Favaloro EJ. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Blood Rev 1999 13 4 185-204 (Pubitemid 30157641)
12. Veyradier A, Fressinaud E, Sigaud M, Wolf M, Meyer D. A new automated method for von Willebrand factor antigen measurement using latex particles. Thromb Haemost 1999 81 2 320-321 (Pubitemid 29078329)
13. Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986 43 3 303-311 (Pubitemid 16060834)
14. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/ von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980 302 19 1047-1051 (Pubitemid 10123105)
15. Scott JP, Montgomery RR. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the neutral monoclonal antibody binding assay. Am J Clin Pathol 1991 96 6 723-728
16. Casonato A, Pontara E, Zerbinati P, Zucchetto A, Girolami A. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol 1998 109 3 347-352 (Pubitemid 28110580)
17. Nishino M, Girma J-P, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989 74 5 1591-1599 (Pubitemid 19251534)
18. Federici AB, Canciani MT, Forza I, Cozzi G. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand diseasesingle center comparison of four different assays. Thromb Haemost 2000 84 6 1127-1128 (Pubitemid 32014059)
19. Eikenboom J, Van Marion V, Putter H et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost 2006 4 4 774-782
20. Sadler JE, Budde U, Eikenboom JC et al, Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006 4 10 2103-2114 (Pubitemid 44403432)
21. Castaman G, Eikenboom JCJ, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999 82 3 1065-1070 (Pubitemid 29419720)
22. Federici AB, Castaman G, Thompson A, Berntorp E. von Willebrand's disease: clinical management. Haemophilia 2006 12 Suppl 3 152-158
23. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003 1 4 682-689
24. Federici AB. Management of von Willebrand disease with factor VIII/ von Willebrand factor concentrates: results from current studies and surveys. Blood Coagul Fibrinolysis 2005 16 Suppl 1 S17-S21 (Pubitemid 40756404)
25. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997 90 7 2515-2521 (Pubitemid 27413458)
26. Lethagen S, Harris AS, Sjörin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 1987 58 4 1033-1036
27. Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia 2004 10 2 158-161 (Pubitemid 38312642)
28. Lethagen S, Carlson M, Hillarp A. A comparative in vitro evaluation of six von Willebrand factor concentrates. Haemophilia 2004 10 3 243-249 (Pubitemid 38584795)
29. Srivastava A, Mathews V, Bhurani D, Baidya S, Chandy M. Successful surgical hemostasis in patients with von Willebrand disease following infusion of KoateDVI. Thromb Haemost 2002 87 3 541-543 (Pubitemid 34232502)
30. Viswabandya A, Mathews V, George B et al. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI. Haemophilia 2008 14 4 763-767 (Pubitemid 352016032)
31. Lethagen S, Kyrle PA, Castaman G, Haertel S, Mannucci PM, HAEMATE P Surgical Study Group. von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery. J Thromb Haemost 2007 5 7 1420-1430 (Pubitemid 46965370)
32. Shortt J, Dunkley S, Rickard K, Baker R, Street A. Efficacy and safety of a high purity, double virus inactivated factor VIII/ von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures. Haemophilia 2007 13 2 144-148 (Pubitemid 46237945)
33. Michiels JJ, Berneman Z, van der Planken M, Schroyens W, Budde U, van Vliet HHDM. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII/von Willebrand concentrate (Haemate-P). Blood Coagul Fibrinolysis 2004 15 323-330 (Pubitemid 38757060)
34. Nossent AY, Dai L, Rosendaal FR, Vos HL, Eikenboom JC. Beta 2 adrenergic receptor polymorphisms: association with factor VIII and von Willebrand factor levels and the risk of venous thrombosis. J Thromb Haemost 2005 3 2 405-407 (Pubitemid 41623640)